Author

Tamás Szamosi 1

1 MHEK,Budapest,Hungary

BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY BASED ON INTERIM RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Klaudia Farkas, Barbara Dorottya Lovasz, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Tünde Kristóf, Peter L Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze;;

CHARACTERISTICS OF ANTI-TNF ALPHA THERAPY FOR ULCERATIVE COLITIS BETWEEN 2010-2016 IN HUNGARY

Anita Balint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Péter Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Tamás Molnár

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

EFFICACY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH SEVERE, THERAPEUTIC RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Peter L Lakatos, Krisztina Barbara Gecse, Petra Anna Golovics, Aron Vincze, Lilla Lakner, Mariann Rutka, Anita Balint, Anna Fabian, Ágnes Milassin, Zoltan Gabor Szepes, Tamás Molnár

EPIDEMIOLOGY, INCIDENCE OF COLORECTAL CANCER, MORTALITY AND THE USE OF BIOLOGICAL THERAPY IN ULCERATIVE COLITIS PATIENTS BETWEEN 2007-2016 IN HUNGARY

Tamás Molnár, Ágnes Milassin, Kata Szántó, Pater Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Klaudia Farkas

FERTILITY AND PREGNANCY IN IBD - OUR EXPERIENCES

Eszter Schäfer, Klára Bursics, Tamás Szamosi, János Banai, Ferenc Zsigmond, Tibor Zoltán Gyökeres, László Herszényi

FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra Anna Golovics, Barbara Dorottya Lovasz, Lorant Gonczi, János Banai, László Bene, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamá

FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PREDICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Petra Anna Golovics, Barbara Dorottya Lovasz, Zsuzsanna Kürti, Mariann Rutka, Zsuzsanna Vegh, Krisztina Barbara Gecse, Klaudia Farkas, János Banai, László Bene, Lorant Gonczi, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Karoly Palatka, Árpád V. Patai, Mária Papp, Ágnes Szabone Salamon, Tamás Szamosi, Zo

FREQUENCY AND CHARACTERISTICS OF INFUSION REACTIONS DURING BIOSIMILAR INFLIXIMAB TREATMENT IN INFLAMMATORY BOWEL DISEASES: RESULTS FROM CENTRAL EUROPEAN NATIONWIDE COHORT

Anita Balint, Mariann Rutka, Zsuzsanna Vegh, Zsuzsanna Kürti, Krisztina Barbara Gecse, János Banai, László Bene, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Karoly Palatka, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze, Renáta Bor, Ágnes Milassi

IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY

Tamás Molnár, Mariann Rutka, Ferenc Nagy, Péter Fritz, László Lakatos, Pal Miheller, Zsuzsanna Erdelyi, Tamás Szamosi, Eszter Schäfer, Aron Vincze, Patrícia Sarlós, János Banai, Ágota Kovács, János Novák, Ágnes Szabone Salamon, Attila Szepes, Nora Szigeti, Mark Juhasz, Katalin Müllner, Zsolt Barta, Orsolya Kadenczki, A

Item 1 - 10 / 26
1
2 3